Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
237.45
+7.90 (3.44%)
At close: May 19, 2026, 4:00 PM EDT
238.57
+1.12 (0.47%)
After-hours: May 19, 2026, 7:50 PM EDT
Jazz Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Jazz Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $248.76. The average 1-year stock price forecast is 4.76% higher than the current stock price, while the lowest is $196 (-17.46%) and the highest is $307 (+29.29%).
Price Target: $248.76 (+4.76%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Jazz Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 4 | 4 | 6 |
| Buy | 8 | 8 | 9 | 8 | 9 | 8 |
| Hold | 2 | 2 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 13 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold → Strong Buy Upgrades $188 → $307 | Hold → Strong Buy | Upgrades | $188 → $307 | +29.29% | May 19, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $220 → $275 | Strong Buy | Maintains | $220 → $275 | +15.81% | May 6, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $195 → $258 | Buy | Maintains | $195 → $258 | +8.65% | May 6, 2026 |
| Barclays | Barclays | Buy Maintains $225 → $234 | Buy | Maintains | $225 → $234 | -1.45% | May 6, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $250 → $265 | Buy | Maintains | $250 → $265 | +11.60% | May 6, 2026 |
Financial Forecast
Revenue This Year
4.61B
from 4.27B
Increased by 7.91%
Revenue Next Year
4.91B
from 4.61B
Increased by 6.71%
EPS This Year
25.82
from -5.84
EPS Next Year
26.24
from 25.82
Increased by 1.64%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 4.8B | 5.3B | ||||||
| Avg | 4.6B | 4.9B | ||||||
| Low | 4.4B | 4.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 12.9% | 14.0% | ||||||
| Avg | 7.9% | 6.7% | ||||||
| Low | 2.3% | -3.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 28.33 | 31.76 | ||||||
| Avg | 25.82 | 26.24 | ||||||
| Low | 23.92 | 22.35 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 23.0% | ||||||
| Avg | - | 1.6% | ||||||
| Low | - | -13.4% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.